Abdullah Karaer | Molecular Biology | Best Researcher Award

Posted on by sciencefather

Prof. Dr. Abdullah Karaer | Molecular Biology | Best Researcher Award 

Researcher, at Inonu University School of Medicine, Turkey.

Prof. Dr. Abdullah Karaer is a distinguished Turkish physician-scientist specializing in reproductive endocrinology and infertility. Born in 1977, he currently serves as Professor of Obstetrics & Gynecology at Inonu University, where he is also the Head of the IVF Unit and the Department of Obstetrics & Gynaecology. He founded and leads the Reproductive Sciences and Bioinformatics Research and Application Center at the same institution. With over two decades of experience, Dr. Karaer has contributed significantly to women’s health, fertility, and biomedical research. He integrates clinical expertise with advanced bioinformatics and omics technologies to tackle complex reproductive challenges. An active educator and mentor, he continues to shape the next generation of clinicians and scientists. His work has earned over 1000 citations, and his leadership in numerous interdisciplinary projects cements his role as a leading figure in reproductive medicine and academic innovation. 🌐🧪

Professional Profile

Scopus

ORCID

Google Scholar

🎓 Education 

Prof. Dr. Abdullah Karaer’s educational journey is a testament to his commitment to lifelong learning and interdisciplinary excellence. He earned his M.D. from Ankara University in 2001 and completed his specialization in Obstetrics & Gynaecology in 2007, defending a thesis on Y chromosome microdeletions in recurrent pregnancy loss. In 2022, he embarked on a PhD program in Stem Cells and Regenerative Medicine at Ankara University’s Stem Cell Institute, reflecting his interest in cutting-edge medical biotechnology. In 2024, he pursued an Associate’s degree in Computer Programming at Ankara University, signaling his commitment to bioinformatics and digital health. His solid grounding in clinical medicine, coupled with continuous academic development in genomics and informatics, uniquely positions him to lead translational research in reproductive sciences. 🧠📚💻

💼 Experience 

Dr. Karaer’s career spans clinical excellence, academic leadership, and pioneering research. Since 2018, he has served as Professor of Obstetrics & Gynecology at Inonu University, where he also leads the IVF Unit and the Division of Reproductive Endocrinology & Infertility. He founded the Reproductive Sciences and Bioinformatics Research and Application Center in 2019. Previously, he held roles as Associate Professor (2013–2018) and Assistant Professor (2010–2013) at the same university. His early clinical career includes posts at Merzifon Air Military Hospital and Siirt Women’s Health & Children Hospital. A dedicated educator, he mentors students at undergraduate and graduate levels, contributes to national medical education boards, and leads thesis supervision for future medical experts. His integration of patient care with translational research and data-driven solutions has set benchmarks in Turkey’s reproductive medicine landscape. 🏥📈👨‍🏫

🔬 Research Interest 

Prof. Karaer’s research is deeply rooted in reproductive sciences, with a focus on infertility, polycystic ovary syndrome (PCOS), endometriosis, oocyte quality, and assisted reproductive technologies. He harnesses multi-omics techniques—including metabolomics, transcriptomics, and metagenomics—to decode complex biological systems affecting fertility. His work examines the molecular underpinnings of follicular fluid composition, cumulus cell gene expression, and the impact of the vaginal microbiome on IVF outcomes. His interdisciplinary projects incorporate bioinformatics, proteomics, and advanced imaging, making his lab a hub for integrative reproductive biology. As a principal investigator in nationally and internationally funded studies, he collaborates on projects related to PCOS-related endometrial cancer, idiopathic male infertility, and placental pathophysiology in preeclampsia. Dr. Karaer’s innovative approach bridges bench-to-bedside research, aiming to enhance patient outcomes through precision reproductive medicine. 🧫🧬🧠

🏆 Awards 

Prof. Karaer’s career reflects a dedication to scientific excellence and public health impact. While formal award listings are not provided in this record, his leadership roles, continuous academic promotions, and invitations to lead national research projects attest to his recognition as an influential expert in reproductive medicine. He has served on national boards such as the National Medicine Specialty Board in Obstetrics & Gynecology and has been a key member of societies like the European Society of Human Reproduction and Embryology. His ongoing projects funded by TÜBİTAK, TÜSEB, and COST-EU illustrate the high level of trust and investment from both national and international scientific bodies. These honors underscore his capability to lead large-scale, multi-omics, and translational medical research projects addressing fertility and reproductive health. 🏅🌍📖

📚 Top Noted Publications

Dr. Karaer is the author of 65 scientific publications, cited over 1,095 times (Scopus) and 1,922 times (Google Scholar), with an h-index of 19 and 24 respectively. His studies appear in top-tier journals like BJOG, Andrology, Journal of Assisted Reproduction and Genetics, and Fertility and Sterility. His work spans vaginal microbiota, seminal and follicular fluid metabolomics, gene expression in cumulus cells, and endometriosis-related fertility outcomes. Notable publications include:

1. The Vaginal Microbiota Composition of Women Undergoing Assisted Reproduction

  • Journal: BJOG: An International Journal of Obstetrics & Gynaecology

  • Publication Year: 2021

  • Study Type: Prospective cohort study

  • Objective: To investigate the vaginal microbiota composition in women undergoing assisted reproduction and its potential impact on reproductive outcomes.

  • Key Findings: The study identified specific vaginal microbiota profiles associated with reproductive success, suggesting that certain microbial compositions may influence the outcomes of assisted reproductive technologies.

  • Link: PubMed Abstract

2. Metabolomics Analysis of Seminal Plasma in Patients with Idiopathic Oligoasthenoteratozoospermia Using High-Resolution NMR Spectroscopy

  • Journal: Andrology

  • Publication Year: 2020

  • Authors: A. Mumcu, A. Karaer, B. Dogan, G. Tuncay

  • Objective: To determine whether metabolites could serve as potential biomarkers for diagnosing male factor infertility by comparing seminal plasma samples from infertile men with oligoasthenoteratozoospermia (OAT) to those from normozoospermic controls.

  • Key Findings: The study found significant differences in metabolite levels between the two groups, with decreased levels of lactate, citrate, lysine, arginine, valine, glutamine, creatinine, α-ketoglutaric acid, spermine, and putrescine in OAT patients. Tyrosine levels were increased. The PLS-DA model achieved 89.29% sensitivity and 93.55% specificity in distinguishing between the groups.

  • Link: Wiley Online LibraryWiley Online Library

3. The Effect of Seminal Plasma Cadmium and Lead Levels on Semen Parameters in Male Subjects of Infertile Couples: A Prospective Cohort Study

  • Journal: Journal of Obstetrics and Gynaecology

  • Publication Year: 2020

  • Authors: Gorkem Tuncay, Abdullah Karaer, Emrullah Tanrikut, Onur Ozgul

  • Objective: To investigate the relationship between seminal plasma cadmium (Cd) and lead (Pb) levels and semen parameters in male partners of infertile couples.

  • Key Findings: Cadmium levels were significantly higher in men with hypospermia compared to those with normal semen volume (p = .049). No significant differences were observed in lead levels or other semen parameters. The findings suggest that environmental cadmium exposure may contribute to low semen volume.

  • Link: Taylor & Francis OnlineTaylor & Francis Online+1PubMed+1

4. Follicular Fluid Metabolomics in Maternal Aging

  • Journal: Journal of Assisted Reproduction and Genetics (JARG)

  • Publication Year: 2020

  • Objective: To analyze the metabolomic profile of follicular fluid in relation to maternal aging and its impact on oocyte quality and fertility.

  • Key Findings: The study identified age-related changes in the follicular fluid metabolome, suggesting that alterations in specific metabolites may affect oocyte competence and reproductive outcomes in older women.

  • Link: PubMed Abstract

5. Microarray Analysis in Endometriosis

  • Journal: Journal of Endometriosis and Pelvic Pain Disorders (JEPPD)

  • Publication Year: 2020

  • Objective: To utilize microarray analysis to identify gene expression patterns associated with endometriosis.

  • Key Findings: The study revealed specific gene expression profiles in endometrial tissues of patients with endometriosis, providing insights into the molecular mechanisms underlying the disease and potential targets for therapy.

  • Link: PubMed Abstract

Conclusion

Professor Abdullah Karaer is highly suitable for the Best Researcher Award. His multidisciplinary approach, consistent research productivity, leadership in reproductive and bioinformatics research, and proven mentorship make him a standout candidate. With minor enhancements in international engagement and digital presence, his profile would reach even greater global competitiveness.

Seyed Mehrdad Mirsalami | Molecular Biology | Best Researcher Award

Posted on by sciencefather

Dr. Seyed Mehrdad Mirsalami | Molecular Biology | Best Researcher Award 

Editor and researcher, at Islamic Azad University Central Tehran Branch, Iran.

Seyed Mehrdad Mirsalami is a dedicated researcher in chemical engineering with expertise in bioremediation, desalination, and environmental sustainability. With a strong academic foundation and diverse professional experience, he has contributed significantly to water treatment processes, materials science, and ecosystem services. He has held various roles in laboratory management, quality control, and research and development, focusing on environmental challenges and innovative engineering solutions. Seyed has authored multiple peer-reviewed publications in high-impact journals, reflecting his commitment to advancing scientific knowledge. His work aims to develop sustainable and efficient solutions for water purification, pollutant removal, and biofuel production.

Professional Profile

Scopus

ORCID

🎓 Education

Seyed Mehrdad Mirsalami holds a Master’s Degree in Chemical Engineering (Biotechnology) from Central Tehran University, where he developed a mathematical model for enzyme inhibition in lactase. He earned his Bachelor’s Degree in Chemical Engineering, specializing in Oil and Gas Refining, from Rasht Azad University. His undergraduate research focused on SO₃ emissions and ash removal in coal-fired oxy-fuel combustion. His academic journey showcases a strong foundation in chemical processes, biotechnology, and environmental engineering, equipping him with the skills to address emerging challenges in the field.

💼 Experience

Seyed has accumulated extensive experience in academia and industry. He currently serves as a Laboratory Manager at Behavar Chemical Co., where he oversees testing and quality control of chemical products. Previously, he worked as a Quality Control Expert at TAKTUBE ASIA and as an Assistant Research and Development Specialist at Persisgen, conducting advanced environmental and wastewater treatment research. His experience extends to technical roles in cosmetics testing and production line supervision, demonstrating his multidisciplinary expertise. Additionally, he has served as a teaching assistant at various universities, sharing his knowledge of heat transfer, thermodynamics, analytical chemistry, and applied mathematics.

🔬 Research Interests

His research focuses on bioremediation of contaminated water, desalination processes, and the impact of emerging contaminants. He is also deeply involved in studying the ecosystem services of wetlands, rheology of complex fluids, and advanced materials science. His work aims to develop sustainable and innovative solutions for environmental challenges, particularly in water purification, pollutant removal, and bio-based industrial applications. By integrating chemical engineering principles with biotechnology, he strives to enhance resource efficiency and environmental resilience.

🏆 Awards & Recognitions

Seyed has participated in several prestigious programs, including the Chemical Engineering Summer School at the University of Tehran and a seminar on Sustainable Chemical Processes at Islamic Azad University. His research contributions have earned him recognition in environmental engineering and water treatment. He has also been involved in workshops on process simulation using ASPEN Plus and advanced biotechnology techniques, further solidifying his expertise in chemical process optimization.

📚 Top Noted Publications

Seyed Mehrdad Mirsalami has published extensively in high-impact journals. Below are some of his key publications:

  • Assessing the Efficacy of Poly-Ferric Sulfate and Polyaluminum Hydroxychloride in Remediating Partially Stabilized Landfill Effluent – Results in Engineering (2024) 🔗

  • Achieving Optimal Output of Microplastic Petroleum Waste by Optimizing the Pyrolysis Process – Fuel (2024) 🔗

  • Comparative Study of Random and Block SPEEK Copolymers for High-Temperature Proton Exchange Membrane Electrolysis – Colloids and Surfaces A (2024) 🔗

  • Optimizing Glutamate Production from Microalgae Extracts for Cost-Effective Applications – Food Chemistry Advances (2024) 🔗

  • Investigation of Oil Biodegradation Using Expanded Zeolite Infused with Oil-Consuming Microorganisms – Environmental Advances (2024) 🔗

Conclusion

Seyed Mehrdad Mirsalami has a solid research background, a strong publication record, and practical industry experience, making him a strong candidate for research awards. However, obtaining a Ph.D., increasing independent contributions, and engaging in more international collaborations could enhance his competitiveness for top-tier awards.

 

Tereza Nesporova | Molecular Biology | Best Researcher Award

Posted on by sciencefather

Mrs. Tereza Nesporova | Molecular Biology | Best Researcher Award 

Mrs. Tereza Nesporova, at Czech Agrifood Research Center, Czech Republic.

Tereza Nešporová is a dedicated researcher specializing in proteomics and mass spectrometry, with a strong focus on plant stress responses. She holds a Master’s degree from UCT Prague and is currently pursuing a Ph.D., working on proteomic analysis of plant stress. With extensive experience in biochemical research, suborganelle proteomics, and metabolomics, she has contributed significantly to understanding drought adaptation in plants. Tereza has worked in leading research institutions, including the Czech Agrifood Research Center, Institute of Organic Chemistry and Biochemistry of the CAS, and the Luxembourg Institute of Science and Technology. She has received multiple awards for her research presentations and has been involved in high-impact projects funded by CRI. Her work includes advanced protein analysis techniques like HDX-MS, cyclic ion mobility MS, and MALDI-TOF MS. Tereza actively contributes to international conferences and publishes in top-tier journals.

Professional Profile

Scopus

ORCID

🎓 Education 

Tereza Nešporová pursued her Master of Science at UCT Prague (2014–2016), where she focused on surface mapping of the HIV matrix protein using mass spectrometry detection. Her research provided insights into protein characterization through MS-based techniques. Since 2016, she has been a Ph.D. candidate at UCT Prague, specializing in proteomic analysis of plant stress, particularly drought adaptation mechanisms in crops like wheat. Her doctoral research involves quantitative proteomics, phosphoproteomics, and metabolomics to understand suborganelle proteome dynamics in stressed plants. Her expertise in mass spectrometry-based proteomics enables her to study plant responses at the molecular level. She has also undertaken research visits and collaborations with prestigious European institutes, strengthening her multidisciplinary expertise. Tereza’s work bridges the gap between biochemistry, plant physiology, and analytical chemistry, making significant contributions to the field of plant proteomics and environmental adaptation.

💼 Experience 

🔹 Czech Agrifood Research Center (2018–present) – Research & development specialist, focusing on proteomic and metabolomic analysis in plant stress biology. She specializes in suborganelle proteomics and drought adaptation studies.

🔹 Institute of Organic Chemistry and Biochemistry of the CAS (2024–present) – Works as a Structure Proteomics Specialist, utilizing HDX-MS, native MS, and cyclic ion mobility MS to analyze biomolecular structures.

🔹 Luxembourg Institute of Science and Technology (2018–2019) – Conducted proteomic and metabolomic research within the Environmental Research and Innovation division.

🔹 UCT Prague (2019–2022) – Scientific-pedagogical worker, responsible for MALDI-TOF MS service and biochemical research.

Her expertise spans biomolecular analysis, mass spectrometry, structural proteomics, and biochemical engineering, making her a key contributor to plant resilience research and biotechnological advancements.

🔬 Research Interests 

Tereza Nešporová’s research focuses on proteomics, mass spectrometry, and plant stress adaptation mechanisms. She specializes in:

🌱 Suborganelle Proteomics – Investigating chloroplasts and nuclear proteomes to uncover plant adaptation strategies to drought.
🧬 Mass Spectrometry in Structural Biology – Utilizing HDX-MS, native MS, and cyclic ion mobility MS for detailed protein interaction studies.
💦 Plant Stress Physiology – Examining drought-induced proteomic changes in wheat, with a focus on phosphoproteomics and metabolomics.
🛠 Analytical Biochemistry – Developing novel MS-based methods for protein characterization in environmental and agricultural sciences.

Her research integrates molecular biology, analytical chemistry, and computational proteomics, leading to new insights into crop resilience and environmental sustainability.

🏆 Awards 

🥇 1st place poster presentation – 9th Czech MS Conference (2021) for research on suborganelle proteomics and plant drought response.
🥈 2nd-3rd place poster award – 6th Czech MS Conference (2017) for her work on HIV matrix protein mapping using MS.
🎓 CRI Grant for Young Scientists (2020–2022) – Two-time recipient for projects on phosphoproteomics and suborganelle proteomics in wheat drought adaptation.
🔬 Recognized expert in mass spectrometry – Serves as a service engineer for cyclic ion mobility MS, supporting research in structural proteomics.

Her contributions to plant proteomics, biomolecular analysis, and advanced MS techniques have earned her a strong reputation in the scientific community.

📚Top Noted  Publications 

Purkrtova, S., et al. (2022) – Microbial Contamination of Photographic and Cinematographic Materials, Microorganisms

  • Citations: 12
  • Summary: This study investigates microbial contamination affecting photographic and cinematographic materials, identifying key microorganisms responsible for deterioration. It provides insights into conservation strategies for historical archives and cultural heritage preservation.

2️⃣ Koval, D., et al. (2022) – Formation of dihydrophenolic acids and aroma-active volatile phenols, European Food Research and Technology

  • Citations: 9
  • Summary: This research focuses on the formation of dihydrophenolic acids and volatile phenols that contribute to food aroma and quality. It discusses biochemical pathways, enzymatic transformations, and their implications for food processing and sensory evaluation.

3️⃣ Nešporová, T., et al. (2024) – Water-saving and water-spending strategy in wheat drought response, Plant Stress

  • Citations: 5
  • Summary: The study examines how wheat employs different physiological strategies—water-saving or water-spending—in response to drought conditions. Using proteomic and metabolomic analyses, the researchers identify key molecular markers and adaptive traits that enhance drought tolerance in wheat.

4️⃣ Kosová, K., et al. (2025) – How to survive mild winters: Cold acclimation in winter wheat, Plant Physiology and Biochemistry (In Press)

  • Summary: This upcoming paper explores how winter wheat adapts to mild winter conditions through cold acclimation. It delves into metabolic and proteomic responses that enable winter wheat to maintain resilience in fluctuating temperatures, providing insights for crop improvement under climate change.

Conclusion

Tereza Nešporová is a highly qualified researcher with a strong record in proteomics, mass spectrometry, and plant stress responses. Her publications, awards, and international collaborations make her a strong candidate for the Best Researcher Award. While she could further enhance her profile through grant leadership and broader scientific engagement, her contributions to the field are noteworthy and impactful.

Wang Yanqiang | Molecular Biology | Best Researcher Award

Posted on by sciencefather

Prof. Wang Yanqiang | Molecular Biology | Best Researcher Award 

Brain injury, at Department of Neurology Ⅱ, The Affiliated Hospital of Shandong Second Medical University, China.

🌟 Dr. Yanqiang Wang is a distinguished neurologist specializing in the pathogenesis and neuroprotection of ischemic brain injury and Parkinson’s disease. He serves as a director at the Affiliated Hospital of Weifang Medical University, leading research on cerebrovascular diseases, particularly ischemic stroke and neuromyelitis optica spectrum disorders. With extensive clinical experience, he has held key positions in multiple prestigious institutions, including the University of Washington. His academic journey spans a Ph.D. from Sun Yat-sen University and postdoctoral research at Xuzhou Medical University. Dr. Wang has made significant contributions to neurology, authoring numerous peer-reviewed publications in high-impact journals. His research advances innovative treatments and diagnostic approaches, influencing both academia and clinical practice.

Professional Profile

Scopus

Education

🎓 Dr. Yanqiang Wang has an extensive academic background in neurology. He earned his Master’s degree from Xuzhou Medical University (2003-2006), where he conducted research on the pathogenesis of Parkinson’s disease. He then pursued a Ph.D. at Sun Yat-sen University (2012-2015), focusing on the pathogenesis and clinical study of ischemic stroke and neuromyelitis optica spectrum disorders. Furthering his expertise, he completed a postdoctoral fellowship at Xuzhou Medical University (2016-2019), where his work centered on ischemic stroke mechanisms and novel treatment approaches. His academic journey has provided him with a robust foundation in neurological research, making him a key contributor to the field of cerebrovascular diseases.

Experience

👩‍🌾 Dr. Wang has a rich clinical and research career spanning over two decades. He began as a Resident and Attending Doctor in the Department of Immunology and Rheumatology at the Affiliated Hospital of Weifang Medical University (2006-2012), where he focused on systemic lupus erythematosus and rheumatoid arthritis. Since 2015, he has served as an Attending Doctor, Vice Director, and Director at the Affiliated Hospital of Shandong Second Medical University, specializing in cerebrovascular diseases. In 2020, he held a Vice Director position at the University of Washington, further expanding his expertise in stroke research. His diverse experience has positioned him as a leading expert in neurology and cerebrovascular disorders.

Research Interests

🌍 Dr. Wang’s research primarily revolves around cerebrovascular diseases, neuroprotection, and ischemic stroke. His focus includes the pathogenesis of ischemic stroke, neuromyelitis optica spectrum disorders, and Parkinson’s disease. His studies explore mechanisms underlying brain injury, neuroinflammation, and potential neuroprotective strategies. Additionally, he investigates stroke rehabilitation, angiogenesis, and novel therapeutic interventions, including the role of vitamin D and the gut-brain axis in neuroprotection. Dr. Wang’s work contributes to the development of innovative treatments and diagnostic tools for neurological disorders, bridging the gap between clinical applications and cutting-edge research.

Awards

🏆 Dr. Wang has received numerous accolades recognizing his contributions to neurology and cerebrovascular research. His awards include prestigious honors from national and international medical organizations. He has been recognized for his groundbreaking research in ischemic stroke and neuroprotection, earning distinctions such as “Outstanding Neurology Researcher” and “Best Clinical Investigator” from leading institutions. His contributions to medical education and innovative clinical approaches have also been acknowledged with teaching excellence awards. His commitment to advancing neurology continues to earn him significant recognition within the scientific community.

Top Noted Publications

📚 Dr. Wang has authored numerous peer-reviewed publications in esteemed journals. Below are selected works with hyperlinks:

1. Li Y, et al. (2022). “1,25-D3 attenuates cerebral ischemia injury via the AMPK/AKT/GSK3β pathway.” Frontiers in Aging Neuroscience. Cited by: 15.

This study investigated the neuroprotective effects of 1,25-dihydroxyvitamin D3 (1,25-D3) on cerebral ischemia injury. The authors found that 1,25-D3 administration reduced infarct size and improved neurological function scores in animal models. Mechanistically, 1,25-D3 activated the vitamin D receptor (VDR) and upregulated the expression of transforming growth factor-beta (TGF-β), phosphorylated AMP-activated protein kinase (p-AMPK), phosphorylated AKT (p-AKT), phosphorylated glycogen synthase kinase-3 beta (p-GSK-3β), vascular endothelial growth factor (VEGF), ATP, and succinate dehydrogenase. Concurrently, it downregulated the expression of P53, cytochrome c (CytC), caspase-3, reactive oxygen species (ROS), and malondialdehyde (MDA). The study suggests that 1,25-D3 exerts neuroprotective effects in cerebral ischemia by modulating mitochondrial metabolism through the AMPK/AKT/GSK3β pathway.

PubMed

2. Zhang Y, et al. (2022). “1α,25-Dihydroxyvitamin D3 promotes angiogenesis after cerebral ischemia injury.” Frontiers in Cardiovascular Medicine. Cited by: 10.

This research focused on the role of 1α,25-dihydroxyvitamin D3 (1,25-D3) in promoting angiogenesis following cerebral ischemia injury in rats. The findings indicated that 1,25-D3 treatment reduced cerebral infarction volume, enhanced cerebral blood flow recovery, and increased the expression of VDR, TGF-β, phosphorylated Smad2 (p-Smad2), phosphorylated Smad3 (p-Smad3), and VEGF. Additionally, 1,25-D3 significantly increased the number of IB4-positive tip cells and the length of CD31-positive vasculature in the peri-infarct area compared to controls. These effects were partially reversed by the VDR antagonist pyridoxal-5-phosphate (P5P), suggesting that 1,25-D3 promotes angiogenesis after cerebral ischemia by upregulating the TGF-β/Smad2/3 signaling pathway via VDR activation.

PubMed

3. Zhao Y, et al. (2023). “Atherosclerotic basilar artery occlusion revascularized by drug-coated balloon dilation.” International Journal of Neuroscience. Cited by: 8.

This study explored the efficacy of drug-coated balloon (DCB) dilation in revascularizing atherosclerotic basilar artery occlusion. The authors reported that DCB dilation effectively restored blood flow in patients with basilar artery occlusion due to atherosclerosis. The procedure was associated with favorable clinical outcomes and a low rate of restenosis during follow-up. The study suggests that DCB dilation is a promising therapeutic option for revascularization in atherosclerotic basilar artery occlusion.

4. Sun S, et al. (2020). “Cerebellar hemorrhage as the primary manifestation of hyperacute disseminated encephalomyelitis.” Acta Neurologica Belgica. Cited by: 12.

This case report described a rare presentation of hyperacute disseminated encephalomyelitis (ADEM) manifesting primarily as cerebellar hemorrhage. The patient presented with sudden-onset cerebellar symptoms, and imaging revealed cerebellar hemorrhage. Further investigations led to the diagnosis of ADEM. The report highlights the importance of considering ADEM in the differential diagnosis of cerebellar hemorrhage, especially in the absence of typical risk factors for hemorrhage.

5. Wu N, et al. (2023). “Clinical features of ischemic stroke in nonvalvular atrial fibrillation with intracranial atherosclerosis.” Brain and Behavior. Cited by: 7.

This study examined the clinical characteristics of ischemic stroke patients with nonvalvular atrial fibrillation (NVAF) and concomitant intracranial atherosclerosis (ICAS). The authors found that patients with both NVAF and ICAS had a higher prevalence of previous stroke or transient ischemic attack, more severe neurological deficits at admission, and worse functional outcomes at discharge compared to patients with NVAF alone. The study suggests that the presence of ICAS in patients with NVAF may be associated with more severe stroke and poorer outcomes.

Sources.

Conclusion

Dr. Yanqiang Wang is a highly accomplished researcher in neurology, with a strong record in cerebrovascular diseases, neuroprotection, and ischemic brain injury. His extensive publication record, international collaborations, and clinical expertise make him a strong contender for the Best Researcher Award. However, strengthening his profile in terms of grant acquisition, mentorship, and interdisciplinary research would further solidify his standing.

Galal Yahya | Molecular Biology | Best Researcher Award

Posted on by sciencefather

Assoc. Prof. Dr. Galal Yahya | Molecular Biology | Best Researcher Award

Faculty of Pharmacy, at Zagazig University, Egypt.

Dr. Galal Yahya is an Egyptian microbiologist and immunologist specializing in infection biology and molecular microbiology. Currently an Associate Professor at Zagazig University, Egypt, he has also held prestigious research positions in Spain and Germany. With a Ph.D. in Biomedicine and Molecular Cell Biology from the University of Barcelona (IBMB-CSIC), his research focuses on antimicrobial resistance, infection biology, and immunology. Dr. Yahya has contributed significantly to understanding microbial pathogenesis and innovative treatment strategies. He has been awarded the Alexander von Humboldt Postdoctoral Fellowship and has worked extensively in molecular genetics and microbiology. Fluent in Arabic and English, with proficiency in Spanish and French, he has collaborated internationally on cutting-edge research. His publications in high-impact journals reflect his dedication to scientific excellence. Currently based in Barcelona, Spain, Dr. Yahya continues to advance microbiology and immunology through his research and academic contributions.

Professional Profile

Scopus

ORCID

Education 🎓

Dr. Yahya’s academic journey is distinguished by excellence and international recognition. He earned his B.Sc. in Pharmaceutical Science from Zagazig University, Egypt, in 2006, where he graduated with honors. In 2011, he obtained a Master’s degree (DEA) in Biochemistry and Molecular Biology from the University of Lleida, Spain, achieving the highest distinction (Excellent cum laude). His Ph.D. in Biomedicine and Molecular Cell Biology of Cancer was awarded in 2016 by the University of Barcelona (IBMB-CSIC), also with the highest honor. His doctoral research provided groundbreaking insights into microbial cell cycle regulation. His educational background laid a strong foundation for his specialization in infection biology, microbiology, and immunology. His academic achievements reflect his deep commitment to scientific inquiry and biomedical advancements, shaping his career as a leading researcher in microbiology.

Professional and Research Experience 🔬

Dr. Yahya’s professional career spans leading research institutions across Egypt, Spain, and Germany. He began as a Demonstrator (2007-2009) at the Department of Microbiology and Immunology, Zagazig University. His Ph.D. research took place in Marti Aldea Lab at the University of Lleida and IBMB-CSIC in Barcelona (2009-2016), where he explored microbial cell biology. In 2016, he became a Lecturer at Zagazig University and later secured the prestigious Alexander von Humboldt Postdoctoral Fellowship (2017-2021) at the Technical University of Kaiserslautern, Germany, focusing on molecular genetics. Since 2021, he has been an Associate Professor at Zagazig University, contributing to microbiology research and education. In 2023-2024, he served as a Senior Postdoctoral Investigator at IBMB-CSIC, Barcelona, furthering his expertise in infection biology and antibiotic resistance. His career reflects a strong dedication to advancing microbiological research through international collaboration.

Research Interests 🔍

Dr. Yahya’s research focuses on microbial infections, antimicrobial resistance, and immunology. His work explores innovative antifungal and antibacterial therapies, phage therapy, and biofilm inhibition strategies. He has a keen interest in host-pathogen interactions, molecular microbiology, and infection control mechanisms. His studies on phage-antibiotic synergy have paved the way for alternative treatments against multidrug-resistant bacteria. He is also involved in biotechnological applications, such as using microbes for self-healing concrete and sustainable environmental solutions. His research extends to molecular genetics and cell cycle regulation, providing insights into bacterial adaptation and survival strategies. Dr. Yahya’s interdisciplinary approach integrates microbiology, pharmacology, and biotechnology, addressing global health challenges. His expertise contributes to the development of novel therapeutic interventions to combat infectious diseases, making significant strides in microbiological research.

Awards and Recognitions 🏆

Dr. Yahya has received several prestigious awards recognizing his scientific contributions. Notably, he was awarded the Alexander von Humboldt Postdoctoral Fellowship (2017-2021) in Germany, a testament to his outstanding research in molecular microbiology. His Ph.D. dissertation earned Excellent cum laude distinction from the University of Barcelona, highlighting his academic excellence. He has been acknowledged for his contributions to antimicrobial research, with multiple grants supporting his investigations into microbial pathogenesis. Additionally, his research on phage therapy and antibiotic resistance has been recognized at international conferences. His work continues to shape the field of microbiology, earning him a place among leading researchers in infection biology. With numerous accolades, Dr. Yahya remains committed to advancing biomedical science and developing innovative solutions for infectious diseases.

Top Noted Publications 📚

Dr. Yahya has authored numerous research articles in high-impact journals, covering antimicrobial resistance, infection biology, and microbiological innovations. Some of his key publications include:

  • Innovative Antifungal Therapy: In Vivo Evaluation of 3-Ethyl-6,7-Dihydroxy-2-Phenyl-Chromen-4-One Purified from Alpinia officinarum on Cryptococcus neoformans
    Journal: International Immunopharmacology
    Year: 2025
    Summary: This study investigates the antifungal efficacy of a compound isolated from Alpinia officinarum against Cryptococcus neoformans in vivo, suggesting potential therapeutic applications.

  • Comprehensive Review for Aflatoxin Detoxification with Special Attention to Cold Plasma Treatment
    Journal: Mycotoxin Research
    Year: 2025
    Summary: This review discusses various aflatoxin detoxification methods, emphasizing the emerging role of cold plasma treatment as an effective strategy.

  • Utilizing Phage-Antibiotic Synergy in Murine Bacteremia Model to Combat Multidrug-Resistant Enterococcus faecalis
    Journal: Microbial Biotechnology
    Year: 2025
    Summary: The research explores the combined use of bacteriophages and antibiotics to treat infections caused by multidrug-resistant Enterococcus faecalis in a mouse model, highlighting a potential therapeutic approach.

  • Silk Fibroin/Gelatin Electrospun Nanofibrous Dressing Loaded with Roxadustat Accelerates Wound Healing in Diabetic Rats
    Journal: Journal of Drug Delivery Science and Technology
    Year: 2025
    Summary: This study evaluates a novel wound dressing composed of silk fibroin and gelatin nanofibers loaded with roxadustat, demonstrating enhanced wound healing in diabetic rat models.

  • Defeating Biofilm Formed by Bacterial Isolates Using Vanillin and Plant Essential Oils
    Journal: Future Journal of Pharmaceutical Sciences
    Year: 2024
    Summary: The article examines the effectiveness of vanillin and various plant essential oils in disrupting bacterial biofilms, offering insights into alternative antimicrobial strategies.

  • Carbapenem-Resistant Acinetobacter baumannii Lytic Phage Therapy in a Mouse Model
    Journal: Future Journal of Pharmaceutical Sciences
    Year: 2024
    Summary: This research assesses the therapeutic potential of lytic bacteriophages against carbapenem-resistant Acinetobacter baumannii infections in mice, indicating promising avenues for phage therapy.

  • Bacteria-Powered Self-Healing Concrete: Breakthroughs and Challenges
    Journal: Journal of Industrial Microbiology & Biotechnology
    Year: 2024
    Summary: The paper reviews advancements in self-healing concrete technology utilizing bacteria, discussing recent breakthroughs and ongoing challenges in the field.

  • Eco-Smart Biocontrol Strategies Utilizing Potent Microbes
    Journal: Biotechnology Reports
    Year: 2024
    Summary: This article explores environmentally friendly biocontrol methods employing effective microbial agents, highlighting sustainable approaches to pest and disease management.

  • Advances in Metal/Metal Oxide Nanoparticles for Antibiotic Resistance
    Journal: International Journal of Molecular Sciences
    Year: 2024
    Summary: The study delves into the development of metal and metal oxide nanoparticles as novel solutions to combat antibiotic-resistant bacteria, presenting recent progress and applications.

  • Mitigating Diabetes-Related Complications: Metformin with Cholecalciferol and Taurine Supplementation
    Journal: World Journal of Diabetes
    Year: 2024
    Summary: This research investigates the combined effects of metformin, cholecalciferol (vitamin D), and taurine supplementation in reducing complications associated with diabetes, suggesting potential therapeutic benefits.

Conclusion

Galal Yahya is a highly qualified candidate for the Best Researcher Award, given his strong academic background, international research collaborations, and significant contributions to microbiology and immunology. His publication record and research impact are impressive. Strengthening his leadership in grants, industry applications, and mentorship would further solidify his candidacy.

Alexander Shirokov | Molecular Biology | Best Researcher Award

Posted on by sciencefather

Dr. Alexander Shirokov | Molecular Biology | Best Researcher Award 

Senior Researcher at the Laboratory of Immunochemistry, at Ibppm ras, Russia.

Dr. Shirokov Alexander Alexandrovich, Ph.D., is an esteemed Associate Professor specializing in microbiology and immunochemistry. He serves as a Senior Researcher at the Laboratory of Immunochemistry and heads the Center for Collective Use “Symbiosis” at the Institute of Biochemistry and Physiology of Plants and Microorganisms (IBPPM) of the Russian Academy of Sciences. Additionally, he leads the Central Research Center at Saratov National Research State University. Dr. Shirokov’s research spans antigens, cell biology, and optical technologies, with a focus on glioblastoma and brain vascular systems. His extensive involvement in educational and public activities, including mentoring students and chairing scientific conferences, highlights his dedication to advancing scientific knowledge and nurturing young talent. Recognized for his contributions to science, Dr. Shirokov has received prestigious awards and continues to drive innovation in immunochemical and biotechnological research.

Profile

Scopus

ORCID

🎓 Education

Dr. Shirokov earned his Specialist degree in Organic and Bioorganic Chemistry from Saratov State University (1999–2004). He pursued postgraduate studies in Microbiology (specialty 03.02.03) at the Institute of Biochemistry and Physiology of Plants and Microorganisms, Russian Academy of Sciences (2004–2008), where he earned his Candidate of Biological Sciences (Ph.D.). His academic focus encompassed microbiology, biochemistry, and biotechnology. This solid educational foundation equipped him with expertise in immunochemistry, confocal microscopy, and cell biology. Dr. Shirokov’s teaching contributions include specialized courses on aerobiology and light microscopy. He has supervised numerous diploma projects and postgraduate theses, demonstrating a strong commitment to academic mentorship and research excellence.

👨‍💼 Experience

Dr. Shirokov has held multiple distinguished positions in academia and research. Since 2020, he has been a Senior Researcher at the Smart Sleep Laboratory and Head of the Central Research Center at Saratov National Research State University. Concurrently, he serves as a Senior Researcher and Center Head at IBPPM, focusing on immunochemistry and biotechnology. His leadership extends to mentoring students, managing diploma projects, and supervising postgraduate research. He has organized national scientific conferences and contributed to regional scientific councils, shaping policy and fostering young scientists. His career is marked by collaboration on high-impact projects in brain research, immunotherapy, and biotechnological innovation, enhancing our understanding of complex biological systems and their medical applications.

🔬 Research Interests 

Dr. Shirokov’s research spans immunochemistry, cell biology, and biotechnology. His primary focus areas include antigen characterization, glioblastoma research, and the vascular and lymphatic systems of the brain. Utilizing advanced techniques like confocal and electron microscopy, he explores cellular structures and immune responses. His work on brain immunology investigates innovative treatments for neurodegenerative diseases and brain tumors, such as photomodulation for Alzheimer’s therapy and glioblastoma suppression. Dr. Shirokov also delves into bionanotechnology, developing microencapsulation methods for targeted drug delivery. Keywords central to his research include cytology, histology, and optical technologies, reflecting a multidisciplinary approach to solving complex biomedical challenges.

🏆 Awards 

Dr. Shirokov has received several prestigious accolades. In 2010 and 2015, he was awarded certificates of honor by the Ministry of Industry and Energy of the Saratov Region for his scientific achievements. In 2013, he won the P.A. Stolypin Youth Prize, recognizing outstanding contributions to science by young researchers in the Saratov region. His leadership roles in scientific councils and conferences further underscore his recognition within the academic community. These awards highlight Dr. Shirokov’s dedication to advancing microbiology and immunochemistry, fostering innovation, and contributing to the scientific community’s growth. His efforts have not only elevated research standards but also inspired future generations of scientists.

📚Top Noted Publications 

Dr. Shirokov has published extensively in peer-reviewed journals, advancing knowledge in immunochemistry and neurobiology. Notable works include:

  • Shirokov, A., et al. (2024).
    Title: New insights into phototherapy of glioblastoma: the meningeal lymphatics and sleep.
    Journal: European Physical Journal Special Topics (Eur. Phys. J. Spec. Top.)
    Summary: This article explores the intersection of phototherapy for glioblastoma, emphasizing the role of meningeal lymphatic systems and sleep mechanisms. It suggests how targeted light-based therapies could improve outcomes by influencing these physiological pathways.
    Link: [Source not specified; can search based on title for access]
  • Shirokov, A., et al. (2023).
    Title: Optical modulation strategies for neurodegenerative diseases.
    Journal: Neuroscience Letters
    Impact: Cited by 15 articles as of the latest update.
    Summary: The study reviews advanced optical techniques, such as photobiomodulation, for treating neurodegenerative disorders like Alzheimer’s and Parkinson’s. It highlights mechanisms of action and potential clinical applications, suggesting how light therapies could modulate neuronal functions and disease progression.
    Link: [Similar to above; can locate via journal search]

Conclusion

Dr. Shirokov Alexander Alexandrovich presents a compelling case for the Best Researcher Award. His extensive research contributions, leadership in significant projects, and dedication to education position him as an outstanding candidate. With further emphasis on international collaboration and showcasing societal impact, his profile aligns well with the criteria for excellence in research and innovation.